The changing scenario of the diabetes epidemic: Implications for India

Indian Journal of Medical Research

Volumn 116, Issue OCT., 2002, Pages 121-132

  Pradeepa, R ^a,b   Mohan, V ^a,b  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b MV Diabetes Specialties Center   (India)

Author keywords

Complications; Diabetes; Epidemic; Indians; Prevention; South Indians

Indexed keywords

GLUCOSE; INSULIN; METFORMIN;

AGE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST OF ILLNESS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET; EPIDEMIC; EUROPE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIA; INDIAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; POPULATION RISK; PREVALENCE; PREVENTION AND CONTROL; REVIEW; RISK FACTOR; SOCIOECONOMICS; URBAN AREA; WEIGHT REDUCTION;

ADOLESCENT; CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMANS; INDIA; INSULIN RESISTANCE; PREVALENCE; SOCIOECONOMIC FACTORS;

EID: 0036819995     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Zimmet P. Globalization, coca-colonization and the chronic disease epidemic: Can the doomsday scenario be averted? J Intern Med 2000; 247: 301-10.
2. Disdier-Flores OM, Rodriguez-Lugo LA, Perez-Perdomo R, Perez-Cardona CM The public health burden of diabetes: A comprehensive review. P R Health Sci J 2001; 20: 123-30.
3. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997; 14 (Suppl 5): S1-85.
4. King H, Aubert RE, Herman, WH. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
5. Songer TJ, Zimmet PZ. Epidemiology of type 2 diabetes: An international perspective. Pharmacoeconomics 1995; 1 (Suppl 8): 1-11.
6. Bjork S. The cost of diabetes and diabetes care. Diabetes Res Clin Pract 2001; 54 (Suppl 1): S13-8.
7. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2002; 25 (Suppl 1): S5-20.
8. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
9. Scott RS, Brown LJ. Prevalence and incidence of insulin-treated diabetes mellitus in adults in Canterbury, New Zealand. Diabet Med 1991; 8: 443-7.
10. Karvonen M, Tuomilehto J, Libman I, LaPorte R. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization Diamond Project Group. Diabetologia 1993; 36: 883-92.
11. Zimmet PZ. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 1999; 42: 499-518.
12. Venkat Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes - A common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 2000; 50 (Suppl 2): S77-S84.
13. Omran AR. The epidemiologic transition theory. A preliminary update. J Trop Pediatr 1983; 29: 305-16.
14. Bennett PH, Burch TA, Miller M. Diabetes mellitus in American (Pima) Indians. Lancet 1971; ii: 125-8.
15. Zimmet P, Taft P, Guinea A, Guthrie W, Thoma K. The high prevalence of diabetes mellitus on a Central Pacific Island. Diabetologia 1977; 13: 111-5.
16. Zimmet P, Dowse G, Finch C, Serjeantson S, King H. The epidemiology and natural history of NIDDM - Lessons from the South Pacific. Diabetes Metab Rev 1990; 6: 91-124.
17. King H, Rewers M, WHO Ad Hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16: 157-77.
18. O'Dea K. Westernization, insulin resistance and diabetes in Australian aborigines. Med J Aust 1991; 155: 258-64.
19. Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology - From west to the rest. Diabetes Care 1992; 15: 232-52.
20. De Courten M, Bennett PH, Tuomilehto J, Zimmet P. Epidemiology of NIDDM in non-Europids. In: Alberti KGGM, Zimmet P, DeFronzo RA, editors. International Textbook of Diabetes Mellitus, 2nd ed. Chichester: John Wiley & Sons; 1997 vol 1, p. 143-70.
21. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia 1997; 40: 232-7.
22. Pradeepa R, Deepa R, Mohan V. Epidemiology of diabetes in India - Current perspective and future projections. J Indian Med Assoc 2002; 100: 144-8.
23. Ahuja MMS. Epidemiology studies on diabetes mellitus in India. In: Ahuja MMS, editor. Epidemiology of Diabetes in Developing Countries. New Delhi: Interprint 1979; p. 29-38.
24. Ramachandran A, Jali MV, Mohan V, Snehalatha C, Viswanathan M. High prevalence of diabetes in an urban population in south India. B M J 1988; 297 : 587-90.
25. Kutty VR, Soman CR, Joseph A, Pisharody R, Vijayakumar K. Type 2 diabetes in southern Kerala: Variation in prevalence among geographic divisions within a region. Natl Med J India 2000; 13 : 287-92.
26. Zargar AH, Khan AK, Masoodi SR, Laway BA, Wani Al, Bashir MI, et al. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. Diabetes Res Clin Pract 2000; 47 : 135-46.
27. Iyer SR, Iyer RR, Upasani SV, Baitule MN. Diabetes mellitus in Dombivli - An urban population study. J Assoc Physicians India 2001; 49 : 713-6.
28. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001; 25 : 1722-9.
29. Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saraja R. Intra-urban differences in the prevalence of the metabolic syndrome in southern India - The Chennai Urban Population Study (CUPS No. 4). Diabet Med 2001; 18 : 280-7.
30. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001; 44 : 1094-101.
31. Ramachandran A, Snehalatha C, Latha E, Manoharan M, Vijay V. Impacts of urbanization on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res Clin Pract 1999; 44 : 207-13.
32. Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol 1998; 66 : 65-72.
33. Ramaiya KL, Kodali VRR, Alberti KGMM. Epidemiology of diabetes in Asians of the Indian subcontinent. Diabetes Metab Rev 1990: 6 : 125-46.
34. Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia 1986; 29 : 235-7.
35. Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EN. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res 1987; 19 : 84-5.
36. Yajnik CS. The insulin resistance epidemic in India: Foetal origins, later lifestyle, or both? Nutr Rev 2001; 59 : 1-9.
37. Gupta A, Gupta R, Lal B, Singh AK, Kothari K. Prevalence of coronary risk factors among Indian physicians. J Assoc Physicians India 2001; 49 : 1148-52.
38. Misra A, Cherukupalli R, Reddy KS, Mohan A, Bajaj JS. Hyperinsulinemia and dyslipidemia in non-obese, normotensive offspring of hypertensive parents in northern India. Blood Press 1998; 7 : 286-90.
39. Misra A. Insulin resistance syndrome: Current perspective and its relevance in Indians. Indian Heart J 1998; 50 : 385-95.
40. Deepa R, Shanthirani CS, Premalatha G, Sastry NG, Mohan V. Prevalence of insulin resistance syndrome in a selected south Indian population - The Chennai Urban Population Study-7 [CUPS No-7]. Indian J Med Res 2002; 115 : 118-27.
41. Misra A, Reddy RB, Reddy KS, Mohan A, Bajaj JS. Clustering of impaired glucose tolerance, hyperinsulinemia and dyslipidemia in young north Indian patients with coronary heart disease: A preliminary case-control study. Indian Heart J 1999; 51 : 275-80.
42. Simmons D, Powell MJ. Metabolic and clinical characteristics of south Asians and Europeans in Coventry. Diabet Med 1993; 10 : 751-8.
43. Shanthi Rani CS, Mohan R, Deepa R, Deepa R, Premalatha G, Ravikumar R, et al. The Chennai Urban Population Study (CUPS) - Methodological Details - (CUPS Paper No. 1). Int J Diabetes Dev Countries 1999; 19 : 149-57.
44. Fagot-Campagna A, Petitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, et al. Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective. J Pediatr 2000; 136 : 664-72.
45. Fagot-Campagna A, Venkat Narayan KM, Imperatore G. Type 2 diabetes in children. Exemplifies the growing problem of chronic diseases. BMJ 2001; 322 : 377-8.
46. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of Type 2 diabetes in youth. Diabetes Care 1999; 22 : 345-54.
47. Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care 2000; 23 : 381-9.
48. Mohan V, Ramachandran A, Snehalatha C, Mohan R, Bharani G, Viswanathan M. High prevalence of maturity-onset diabetes of the young (MODY) among Indians. Diabetes Care 1985; 8 : 371-4.
49. Mohan V, Alberti KGMM. Diabetes in the tropics. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, editors. International Textbook of Diabetes Mellitus, 1st ed. Chichester : John Wiley; 1992 p. 177-96.
50. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group, WHO Tech Rep Ser No. 727. Geneva : WHO; 1985.
51. Harris MI, Zimmet P. Classification of diabetes mellitus and other categories of glucose intolerance In: Alberti, KGMM, Zimmet P, DeFronzo R, editors. International Textbook of Diabetes Mellitus, 2nd ed. Chichester : John Wiley and Sons; 1997 vol. 1, p. 9-24.
52. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
53. Zargar AH, Wani Al, Masoodi SR, Laway BA, Bashir MI. Mortality in diabetes mellitus-data from a developing region of the world. Diabetes Res Clin Pract 1999; 43 : 67-74.
54. Turtle JR. The economic burden of insulin resistance. Int J Clin Pract Suppl 2000; 113 : 23-8.
55. Patel JC. Complications in 8793 cases of diabetes mellitus 14 years study in Bombay Hospital, Bombay, India. Indian J Med Sci 1989; 43 : 177-83.
56. Ramachandran A, Snehalatha C, Vijay V, King H. Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabet Med 2002; 19 : 130-5.
57. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97 : 596-601.
58. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339 : 229-34.
59. Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001; 38 : 682-7.
60. Ramachandran A, Snehalatha C, Latha E, Satyarani K, Vijay V. Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care 1998; 21 : 967-71.
61. McKeigue PM. Coronary heart disease in Indians, Pakistanis, and Bangladeshis: Aetiology and possibilities for prevention. Br Heart J 1992; 67 : 341-2.
62. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996; 48 : 343-53.
63. Mohan V, Ravikumar R, Shanthi Rani S, Deepa R. Intimal medial thickness of the carotid artery in south Indian diabetic and non-diabetic subjects: The Chennai Urban Population Study (CUPS). Diabetologia 2000; 43 : 494-9.
64. Beach KW, Brunzell JD, Strandness DE Jr. Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus. Relation to smoking and form of therapy. Arteriosclerosis 1982; 2 : 275-80.
65. Nicholl CG, Levy JC, Mohan V, Rao PV, Mather HM. Asian diabetes in Britain: A clinical profile. Diabet Med 1986; 3: 257-60.
66. Jialal I, Welsh NH, Joubert SM, Rajput MC: Vascular complications in non-insulin-dependent diabetes in the young. S Afr Med J 1982; 62: 155-7.
67. Mohan V, Premalatha G, Sastry NG: Peripheral vascular disease in non-insulin-dependent diabetes mellitus in South India. Diabetes Res Clin Pract 1995; 27: 235-40.
68. Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected South Indian population. The Chennai Urban Population Study. Diabetes Care 2000; 23: 1295-300.
69. Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-92.
70. Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: A comparison of diabetic and non-diabetic subjects in an English community. Diabet Med 1992; 9: 710-5.
71. Beks PJ, Mackaay AJC, De Neeling JND, De Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: The Hoorn study. Diabetologia 1995; 38: 86-96.
72. Katsilambros NL, Tsapogas PC, Avranitis MP, Tritos NA, Alexiou ZP, Rigas KL. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. Diabet Med 1996; 13: 243-6.
73. Beach KW, Bedford GR, Bergelin RO, Martin DC, Vandenberghe N, Zaccardi M, et al. Progression of lower-extremity arterial occlusive disease in type II diabetes mellitus. Diabetes Care 1988; 11: 464-72.
74. Samantha A, Burden AC, Jagger C. A comparison of the clinical features and vascular complications of diabetes between migrant Asians and Caucasians in Leicester, U.K. Diabetes Res Clin Pract 1991; 14: 205-13.
75. Weerasuriya N, Siribaddana S, Dissanayake A, Subasinghe Z, Wariyapola D, Fernando DJS. Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. Q J M 1998; 91: 439-43.
76. Ramu M, Premalatha G, Deepa R, Mohan V. Prevalence of neuropathy using biothesiometry in a selected South Indian Population - The Chennai Urban Population Study (CUPS). Diabetes Res Clin Pract 2000; 50 (Suppl 1): S270.
77. Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in south India. J Assoc Physicians India 2002; 50: 546-50.
78. Rema M, Ponnaiya M, Moham V. Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes centre in southern India. Diabetes Res Clin Pract 1996; 34: 29-36.
79. Rema D, Deepa R, Mohan V. Prevalence of retinopathy at diagnosis among type 2 diabetic patients attending a diabetic centre in south India. Br J Ophthalmol 2000; 84: 1058-60.
80. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthalmol 1999; 83: 937-40.
81. Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self reported diabetics in southern India: A population based assessment. Br J Ophthalmol 2002; 86: 1014-8.
82. Rema M, Shanthirani CS, Deepa R, Mohan V. Prevalence of retinopathy in a selected South Indian Population in the Chennai Urban Population Study (CUPS). Diabetes Res Clin Pract 2000; 50 (Suppl 1): S252.
83. Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabet Med 2002; 14: 910-6.
84. Hawrami K, Mohan R, Mohan V, Hitman GA. A genetic study of retinopathy in south Indian type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 441-4.
85. Hawrami K, Hitman GA, Rema M, Snehalatha C, Viswanathan M, Ramachandran A, Mohan V. An association in non-insulin-dependent diabetes mellitus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphism. Hum Immunol 1996; 46: 49-54.
86. Radha V, Rema M, Mohan V. Genes and diabetic retinopathy. Indian J Ophthalmol 2002; 50: 5-11.
87. Kumaramanickavel G, Sripriya S, Vellanki RN, Upadyay NK, Badrinath SS, Arokiasamy T, et al. Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India. Diabetes Res Clin Pract 2001; 54: 89-94.
88. Kumaramanickavel G, Sripriya S, Vellanki RN, Upadyay NK, Badrinath SS, Rajendran V, et al. Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients. Clin Genet 2002; 61: 344-8.
89. McGowan T, McCue P, Sharma K. Diabetic nephropathy. Clin Lab Med 2001; 21: 111-46.
90. Mather HM, Chaturvedi N, Kehely AM. Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med 1998; 15: 672-7.
91. Allawi J, Rao PV, Gilbert R, Scott G, Jarrett RJ, Keen H, et al. Microalbuminuria in non-insulin-dependent diabetes: Its prevalence in Indian compared with Europid patients. BMJ 1988; 296: 462-4.
92. Mohan V, Deepa R, Shanthirani S, Rema M. Prevalence of Microalbuminuria in a selected South Indian Population - The Chennai Urban Population Study (CUPS). Diabetes Res Clin Pract 2000; 50 (Suppl 1): S261.
93. Mohan V, Meera R, Premalatha G, Deepa R, Miranda P, Rema M. Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India. Postgrad Med J 2000; 76: 569-73.
94. Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in Type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J 2001; 77: 399-402.
95. Gupta DK, Verma LK, Khosla PK, Dash SC. The prevalence of microalbuminuria in diabetes: A study from north India. Diabetes Res Clin Pract 1991; 12: 125-8.
96. Vijay V, Snehalatha C, Ramachandran A, Viswanathan M. Prevalence of proteinuria in non-insulin dependent diabetes. J Assoc Physicians India 1994; 42: 792-4.
97. John L, Sunder Rao PSS, Kanagasabapathy AS. Prevalence of diabetic nephropathy in non-insulin dependent diabetics. Indian J Med Res 1991; 94: 24-9.
98. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
99. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
100. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-17.
101. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth. Diabetologia 1993; 36: 62-7.
102. Yajnik CS, Fall CHD, Vaidya U, Pandit AN, Bavdekar A, Bhat DS, et al. Foetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet Med 1995; 12: 330-6.
103. Yajnik CS. The lifecycle effects of nutrition and body size on adult adiposity, diabetes and cardiovascular disease. Obes Rev 2002; 3: 217-24.
104. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-44.
105. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes Research Group. Diabetes Care 1999; 22: 623-34.
106. Larkin, M. Diet and exercise delay onset of type 2 diabetes, say US experts. Lancet 2001; 358: 565.
107. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerances. Finnish Diabetes Prevention Study Group. N Engl J Med 2001; 344: 1343-50.